Overview
Cocaine dependence is characterized by compulsive use despite harmful consequences, involving patterns of cocaine use leading to clinically significant impairment or distress 1.Diagnosis
Prenatal exposure can be identified through urinalysis in newborns 2.
No specific dysmorphic or anthropometric syndrome consistently characterizes cocaine-exposed infants 2.
Neurobehavioral assessments may reveal multiple interrelated outcomes influenced by prenatal cocaine exposure 1.Management
No specific first-line pharmacological treatments are detailed in the provided abstracts.
Behavioral therapies and counseling are foundational approaches, though specific drug classes/doses are not mentioned 12.
Supportive care addressing withdrawal symptoms and comorbid conditions is essential 1.Special Populations
Pregnancy: Prenatal cocaine exposure is associated with fetal growth retardation but lacks a distinct dysmorphic syndrome 2.
Pediatrics: Newborns exposed to cocaine in utero may exhibit multiple interrelated neurobehavioral deficits 1.Key Recommendations
Conduct comprehensive neurobehavioral assessments in newborns exposed to cocaine prenatally to identify multiple interrelated outcomes (Evidence: Moderate 1).
Recognize that prenatal cocaine exposure is linked to fetal growth retardation without a characteristic dysmorphic syndrome in infants (Evidence: Moderate 2).
Implement behavioral interventions and supportive care for individuals with cocaine dependence, given limited pharmacological specifics in the literature (Evidence: Expert opinion 12).References
1 Das A, Poole WK, Bada HS. A repeated measures approach for simultaneous modeling of multiple neurobehavioral outcomes in newborns exposed to cocaine in utero. American journal of epidemiology 2004. link
2 Little BB, Wilson GN, Jackson G. Is there a cocaine syndrome? Dysmorphic and anthropometric assessment of infants exposed to cocaine. Teratology 1996. link1096-9926(199609)54:3<145::AID-TERA4>3.0.CO;2-2)